Ark Clinical Research, LLC

1. Teva Pharmaceuticals USA, Inc. $175,748 39 payments
2. AstraZeneca Pharmaceuticals LP $43,175 2 payments
3. AstraZeneca AB $38,699 1 payment
4. Taro Pharmaceuticals USA, Inc. $10,522 5 payments
5. Moderna TX, Inc. $86 2 payments

1. An Open Label, Single Dose, 3-Period, Crossover Study to Determine the Pharmacokinetic Profile and Safety of Fluticasone Propionate/Albuterol Sulfate (Fp/ABS) Multidose Dry Powder Inhaler with e-Module (eMDPI) Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Participants with Asthma (4 to 11 Years Old) $91,986 10 payments
2. Study to Evaluate the Efficacy, Safety, Tolerability, and Immunogenicity of TEV-45779 Compared to XOLAIR (Omalizumab) in Patients With Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic Despite Antihistamine (H1) Treatment $73,639 17 payments
3. A Randomized Double-Blind Parallel Group Multi-Center 24-Week Study Comparing the Efficacy and Safety of Three Doses of PT001 to Placebo and Open-label Spiriva Respimat in Subjects With Persistent Asthma $43,175 2 payments
4. A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma. $38,699 1 payment
5. A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler in Patients Aged 4 Through 11 Years With Persistent Asthma $8,437 1 payment
6. A Study to Evaluate the Safety and Bioequivalence of Mupirocin Calcium Cream, 2 and Bactroban Cream and Compare Both to a Vehicle in Treatment of Secondarily Infected Traumatic Skin Lesions $4,312 2 payments
7. Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris $3,402 2 payments
8. A Randomized, Double-Blind, Multiple Center Placebo Controlled Study Comparing Taro Product to RLD and Both Treatments to a Placebo Control in the Treatment of Acne Vulgaris $2,808 1 payment
9. A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma $935 6 payments
10. A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma $750 5 payments

1. Professional salary support $7,272 4 payments
2. Overhead $3,250 1 payment

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.